CoreWeave says it won't increase its $9B offer for data center provider Core Scientific, despite opposition to the deal from major Core Scientific shareholders
Context & Ripple Effects
Core Scientific had already rejected CoreWeave’s earlier $5.75-per-share approach as undervaluing the company. The companies later announced a roughly $9B all-stock acquisition agreement intended to add AI data-center capacity.
The immediate fault line is consideration: reported hedge-fund resistance had centered on better terms after CoreWeave’s share-price decline complicated the stock deal’s value. CoreWeave’s refusal to raise its offer turns that disagreement into a clear shareholder-choice test.
First-order effects
- CoreWeave keeps the proposed transaction’s $9B terms intact rather than paying more to win over opposing Core Scientific holders.
- Core Scientific shareholders must decide whether to accept the existing all-stock consideration or block the deal; management has no announced higher bid to present.
Second-order effects
- A failed or delayed vote would leave CoreWeave without the planned acquisition route to Core Scientific’s data-center footprint, requiring it to rely on other capacity-expansion paths.
- The standoff puts greater weight on CoreWeave’s equity value in negotiations: because the consideration is stock, shareholder support can shift with the perceived value of the offer even without a change to the headline price.
Third-order effects
- As AI-compute providers pursue power and data-center capacity through acquisitions, target shareholders may demand deal structures that better protect value when the buyer’s shares are volatile.
- If such resistance persists, infrastructure consolidation may favor more flexible consideration and direct capacity arrangements over simple all-stock takeovers.
The trend: AI infrastructure companies are treating data-center capacity as a strategic constraint, while investors increasingly scrutinize whether stock-funded acquisitions fairly transfer that value to targets.